Systemic sclerosis associated myopathy.
Chaigne B, Léonard-Louis S, Mouthon L.
Autoimmun Rev. 2023 Feb;22(2):103261. doi: 10.1016/j.autrev.2022.103261. Epub 2022 Dec 20.
Myopathy in systemic sclerosis.
Connolly CM, Paik JJ.
Curr Opin Rheumatol. 2023 Nov 1;35(6):341-348. doi: 10.1097/BOR.0000000000000966. Epub 2023 Aug 22.
Systemic sclerosis-associated myopathy.
Ranque B, Authier FJ, Berezne A, Guillevin L, Mouthon L.
Ann N Y Acad Sci. 2007 Jun;1108:268-82. doi: 10.1196/annals.1422.029.
Myopathy in scleroderma and in other connective tissue diseases.
Paik JJ.
Curr Opin Rheumatol. 2016 Nov;28(6):631-5. doi: 10.1097/BOR.0000000000000336.
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis.
Giannini M, Ellezam B, Leclair V, Lefebvre F, Troyanov Y, Hudson M, Senécal JL, Geny B, Landon-Cardinal O, Meyer A.
Front Immunol. 2023 Jan 26;13:974078. doi: 10.3389/fimmu.2022.974078. eCollection 2022.
Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies.
Paik JJ, Mammen AL, Wigley FM, Gelber AC.
Curr Opin Rheumatol. 2014 Mar;26(2):124-30. doi: 10.1097/BOR.0000000000000024.
Scleroderma-like cutaneous syndromes.
Mori Y, Kahari VM, Varga J.
Curr Rheumatol Rep. 2002 Apr;4(2):113-22. doi: 10.1007/s11926-002-0006-0.
Muscle disease in scleroderma.
Paik JJ.
Curr Opin Rheumatol. 2018 Nov;30(6):576-580. doi: 10.1097/BOR.0000000000000552.
Corticosteroids in Myositis and Scleroderma.
Postolova A, Chen JK, Chung L.
Rheum Dis Clin North Am. 2016 Feb;42(1):103-18, ix. doi: 10.1016/j.rdc.2015.08.011. Epub 2015 Oct 26.
Inflammatory ocular myopathy in systemic sclerosis (scleroderma). A case report and review of the literature.
Arnett FC, Michels RG.
Arch Intern Med. 1973 Nov;132(5):740-3.
